2-STEP CHROMATOGRAPHIC PURIFICATION OF HUMAN PLASMA ALPHA(1)-ACID GLYCOPROTEIN - ITS APPLICATION TO THE PURIFICATION OF RARE PHENOTYPE SAMPLES OF THE PROTEIN AND THEIR STUDY BY CHROMATOGRAPHY ON IMMOBILIZED METAL CHELATE AFFINITY ADSORBENT
F. Herve et al., 2-STEP CHROMATOGRAPHIC PURIFICATION OF HUMAN PLASMA ALPHA(1)-ACID GLYCOPROTEIN - ITS APPLICATION TO THE PURIFICATION OF RARE PHENOTYPE SAMPLES OF THE PROTEIN AND THEIR STUDY BY CHROMATOGRAPHY ON IMMOBILIZED METAL CHELATE AFFINITY ADSORBENT, Journal of chromatography B. Biomedical applications, 678(1), 1996, pp. 1-14
Citations number
32
Categorie Soggetti
Chemistry Analytical","Biochemical Research Methods
Journal title
Journal of chromatography B. Biomedical applications
alpha(1)-Acid glycoprotein (AAG) or orosomucoid was purified to homoge
neity from human plasma by a separate two-step method using chromatogr
aphy on immobilized Cibacron Blue F3G-A to cross-linked agarose and ch
romatography on hydroxyapatite. The conditions for the pre-purificatio
n of AAG by chromatography on immobilized Cibacron Blue F3G-A were fir
st optimized using different buffer systems with different pH values.
The overall yield of the combined techniques was 80% and ca. 12 mg of
AAG were purified from an initial total amount of ca. 15 mg in a ca. 4
0 mi sample of human plasma. This method was applied to the purificati
on of AAG samples corresponding to the three main phenotypes of the pr
otein (F1S/A, F1/A and S/A), from individual human plasma previously
phenotyped for AAG. A study by isoelectric focusing with carrier ampho
lytes showed that the microheterogeneity of the purified F1S/A, F1/A
and S/A AAG samples was similar to that of AAG in the corresponding pl
asma, thus suggesting that no apparent desialylation of the glycoprote
in occurred during the purification steps. This method was also applie
d to the purification of AAG samples corresponding to rare phenotypes
of the protein (F1/AAD, S/A*X(o) and F1/A*C1) and the interactions of
these variants with immobilized copper(II) ions were then studied at
pH 7, by chromatography on an iminodiacetate Sepharose-Cu(II) gel. It
was found that the different variants encoded by the first of the two
genes coding for AAG in humans (i.e. the F1 and S variants) interacted
non-specifically with the immobilized ligand, whereas those encoded b
y the second gene of AAG (i.e. the A, AD, X(o) and C1 variants) strong
ly bound to immobilized Cu(LI) ions. These results suggested that chro
matography on an immobilized affinity Cu(II) adsorbent could be helpfu
l to distinguish between the respective products of the two highly pol
ymorphic genes which code for human AAG.